A retrospective analysis of the role of gefitinib in the definitive management of esophageal/gastroesophageal junction (E/GEJ) cancer.
Davendra Sohal
No relevant relationships to disclose
Thomas W. Rice
No relevant relationships to disclose
Lisa A. Rybicki
No relevant relationships to disclose
Cristina P. Rodriguez
No relevant relationships to disclose
Gregory M. M. Videtic
No relevant relationships to disclose
Jerrold P. Saxton
No relevant relationships to disclose
Sudish C. Murthy
No relevant relationships to disclose
David P. Mason
No relevant relationships to disclose
Brooke Elizabeth Phillips
No relevant relationships to disclose
Raymond R. Tubbs
No relevant relationships to disclose
Thomas Plesec
No relevant relationships to disclose
Michael J. McNamara
No relevant relationships to disclose
Denise I. Ives
No relevant relationships to disclose
Joanna Bodmann
No relevant relationships to disclose
David J. Adelstein
Research Funding - AstraZeneca; GlaxoSmithKline; Sanofi